Development of pathways of insulin secretion in the rabbit.
Insulin release was studied in vitro using pieces of pancreas from rabbits of between 24 days gestational age and 6 weeks postnatal age. When allowance was made for the fraction of pancreas which was endocrine, 16-5mM-glucose caused increasing stimulation of insulin release as development advanced and 3-3 mM-glucose caused a similar rate of secretion at all ages. Secretion was not significantly influenced by insulin destruction in the incubation medium. Glucagon (5 mug/ml) did not stimulate insulin secretion from 24-day foetal pancreas but did so postnatally. Theophylline (1 mmol/1) stimulated insulin release at all ages and was equipotent on 24-day foetal pancreas in 3-3 or 16-5 mM-glucose. The stimulation of insulin release from 24-day foetal pancreas by 1 mM-theophylline occurred in the absence of extracellular glucose, pyruvate, fumarate and glutamate and in the presence of mannoheptulose and 2-deoxyglucose (each 3 mg/ml). Adrenaline (1 mumol/1) and diazoxide (250 mug/ml) abolished or attenuated the stimulation of insulin release by glucose, leucine plus arginine or theophylline from 24-day foetal, 1 day and 6 weeks postnatal pancreas. The stimulation of insulin release from 6-week-old pancreas by 1mM-barium was blocked by adrenaline and diazoxide but the effect became less with increasing immaturity. The experimental results illustrate some of the ways in which insulin secretion by the rabbit beta cell changes as a function of development and draw attention to the importance of glucose and cyclic adenosine monophosphate in this process.
D000367:Age Factors; D000818:Animals; D000831:Animals, Newborn / Q000502:physiology*; D001120:Arginine / Q000494:pharmacology; D001464:Barium / Q000494:pharmacology; D003847:Deoxyglucose / Q000494:pharmacology; D003981:Diazoxide / Q000494:pharmacology; D004837:Epinephrine / Q000494:pharmacology; D005865:Gestational Age; D005934:Glucagon / Q000494:pharmacology; D005947:Glucose / Q000494:pharmacology; D006539:Heptoses / Q000494:pharmacology; D066298:In Vitro Techniques; D007328:Insulin / Q000378:metabolism*; D007329:Insulin Antagonists; D000078790:Insulin Secretion; D007515:Islets of Langerhans / Q000378:metabolism*; D007661:Ketoses / Q000494:pharmacology; D007930:Leucine / Q000494:pharmacology; D010179:Pancreas / Q000187:drug effects / Q000196:embryology / Q000254:growth & development; D011188:Potassium / Q000494:pharmacology; D011817:Rabbits; D013696:Temperature; D013806:Theophylline / Q000494:pharmacology
D006539:Heptoses; D007328:Insulin; D007329:Insulin Antagonists; D007661:Ketoses; D001464:Barium; D005934:Glucagon; D001120:Arginine; D003847:Deoxyglucose; D013806:Theophylline; D007930:Leucine; D005947:Glucose; D003981:Diazoxide; D011188:Potassium; D004837:Epinephrine